U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06793826) titled 'Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea' on Jan. 21.
Brief Summary: Primary objectives:
To investigate the incidence of adverse events occurred following administration of Hexaxim in infants from 2 months of age under routine clinical practice, as per approved indications
Study Start Date: Jan. 22
Study Type: OBSERVATIONAL
Condition:
Hepatitis B
Haemophilus Influenzae Type b Immunisation
Intervention:
BIOLOGICAL: DTaP-IPV-Hep B-PRP-T combined vaccine
prefilled syringe injection intramuscular
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sanofi Pasteur, a Sanof...